Cite
HARVARD Citation
Laetsch, T. et al. (2019). Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial. Lancet oncology. 20 (12), pp. 1710-1718. [Online].